Evidence map›Paper›PMID 22894932›Full record

ArticleCell cycle (Georgetown, Tex.)2012

Androgen receptor serine 81 mediates Pin1 interaction and activity.

Raffaele La Montagna, Isabella Caligiuri, Pasquale Maranta, Chiara Lucchetti, Luca Esposito, Marco G Paggi, Giuseppe Toffoli, Flavio Rizzolio, Antonio Giordano

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Proline-Directed Androgen Receptor Phosphorylation.Journal of molecular and genetic medicine : an international journal of biomedical research · 2013
    Article
  16. Article
  17. Phosphorylation: a fundamental regulator of steroid receptor action.Trends in endocrinology and metabolism: TEM · 2013
    Review
  18. Posttranslational modification of the androgen receptor in prostate cancer.International journal of molecular sciences · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Raffaele La MontagnaSbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.
Isabella Caligiuri
Pasquale Maranta
Chiara Lucchetti
Luca Esposito
Marco G Paggi
Giuseppe Toffoli
Flavio Rizzolio
Antonio Giordano
Philadelphia University · USTemple University · USScientific Research Institute of Experimental and Clinical Medicine · RUTemple College · USUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hormone-dependent tumors are characterized by deregulated activity of specific steroid receptors, allowing aberrant expression of many genes involved in cancer initiation, progression and metastasis. In prostate cancer, the androgen receptor (AR) protein has pivotal functions, and over the years it has been the target of different drugs. AR is a nuclear receptor whose activity is regulated by a phosphorylation mechanism controlled by hormone and growth factors. Following phosphorylation, AR interacts with many cofactors that closely control its function. Among such cofactors, Pin1 is a peptidyl-prolyl isomerase that is involved in the control of protein phosphorylation and has a prognostic value in prostate cancer. In the present study, we demonstrate that ARSer81 is involved in the interaction with Pin1, and that this interaction is important for the transcriptional activity of AR. Since Pin1 expression positively correlates with tumor grade, our results suggest that Pin1 can participate in this process by modulating AR function.

Indexed as

Cell Line, TumorDihydrotestosteroneGene Expression Regulation, NeoplasticHumansNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePhosphorylationPromoter Regions, GeneticProtein BindingProtein Structure, TertiaryReceptors, AndrogenSerineStructure-Activity RelationshipTranscriptional ActivationAR protein, humanDihydrotestosteroneNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePIN1 protein, humanReceptors, AndrogenSerine

Identifiers

PMID22894932
PMCPMC3466552
OpenAlexW2044466825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.